DNA building blocks found in asteroids for first time
The building blocks of DNA have been found in samples returned to Earth from an asteroid, suggesting life rained down from space and could have formed elsewhere.
In 2016, Nasa sent its Osiris-Rex mission to drill down into the asteroid Bennu, with the cargo returning to Earth in 2023.
The first analysis shows that the four nucleotide bases of DNA – adenine, guanine, cytosine and thymine – which form the rungs of the double helix, were all present.
Every living thing on Earth contains DNA, which stores the genetic information needed to build and maintain an organism.
It is the first time that all four nucleotide bases have been discovered together on an asteroid, and the samples were also found to contain 14 of the 20 amino acids that life on Earth uses to make proteins.
Nasa said the findings not only suggest that space rocks sparked life on Earth, but that the conditions for life were widespread across the early solar system.
Nicky Fox, the associate administrator for the Nasa Science Mission Directorate, said: 'Bennu contains many precursor building blocks of life along with the evidence it comes from an ancient wet world.
'The findings do not show evidence for life itself, but they do show that the conditions necessary for the emergence of life were likely widespread across the early solar system. This of course increases the odds that life could have formed on other planets.
'This all supports the theory that Bennu [was] among the sources that delivered water and chemical building blocks for life to Earth.'
Scientists also discovered 11 important minerals, including sodium, carbon, sulphur and phosphorus, which were left behind when saltwater streams evaporated.
Researchers believe these extraterrestrial sub-surface ponds may have provided a cauldron where the elemental ingredients for life could intermingle and create more complex molecules.
Similar conditions are thought to exist on Ceres – a dwarf planet in the asteroid belt between Mars and Jupiter – which suggests it would be a good place to look for the existence of life.
Sara Russell, a cosmic mineralogist at the Natural History Museum in London, who studied the material, said: 'There were things in the samples that completely blew us away. The richness of the molecules and minerals preserved are unlike any extraterrestrial samples studied before.
'It's interesting that although Bennu had everything needed for life – it did not form.
'The complex and delicate conditions needed to catalyse life really bring into focus the abundance of biodiversity here on Earth.'
She added: 'Together we have made huge progress in understanding how asteroids like Bennu evolved, and how they may have helped make the Earth habitable.'
Bennu is more than four-and-a-half billion years old and is a relic from the formation of the solar system which has been perfectly preserved in the vacuum of space.
It is about 1,640ft (500m) across and once belonged to a much larger asteroid which broke apart billions of years ago.
Scientists have long suspected that the ingredients for life on Earth were delivered to our planet by asteroids, but they are tricky to study once on the ground because they are easily contaminated.
The Osiris-Rex mission collected around four ounces (113g) of rock and dust from Bennu – about the weight of a bar of soap – and the samples were divided up and sent to laboratories around the world for study.
Among the new findings were some more familiar minerals such as halite, which is made of sodium chloride and is more commonly called rock salt.
Tim McCoy, the curator of meteorites at the Smithsonian's Museum of Natural History, in Washington DC, added: 'We now know from Bennu that the raw ingredients of life were combining in really interesting and complex ways.
'We have discovered the next step on a pathway to life. We now know we have the basic building blocks to move along this pathway towards life, but we don't know how far along that pathway this environment could allow things to progress.'
The research was published in the journal Nature Astronomy.
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


USA Today
30 minutes ago
- USA Today
Sonic boom rattles Southern California as SpaceX Dragon streaks across sky before landing
Sonic boom rattles Southern California as SpaceX Dragon streaks across sky before landing A SpaceX vehicle that has spent about a month docked at the International Space Station on a resupply mission triggered a sonic boom as it made landing off the coast of California on Saturday night, after many reported seeing the craft streak across the sky. NASA provided live coverage as the uncrewed spacecraft began its return voyage Thursday, May 22. The Dragon capsule, developed by Elon Musk's commercial spaceflight company to deliver cargo and crews to the orbital outpost, embarked on a long voyage ending with a splashdown landing Saturday, May 24 off the coast of California. The vehicle arrived in April with plenty of food, equipment and other supplies for the seven astronauts currently living aboard the station. And it didn't leave emptyhanded: It was loaded up with scientific research samples and hardware. Here's what to know about the resupply mission: What is the International Space Station? For 25 years, the International Space Station has been stationed in low-Earth orbit, typically about 250 miles high, where it has been home to astronauts from all over the world. The orbital laboratory is operated through a global partnership of space agencies, including NASA, Roscosmos, the European Space Agency, the Japan Aerospace Exploration Agency (JAXA) and the Canadian Space Agency (CSA). More than 280 spacefarers from 23 countries have visited the International Space Station, including 169 from the United States alone, according to NASA. Bigger than a six-bedroom house, the outpost has six sleeping quarters, two bathrooms, a gym and a 360-degree view bay window. As of now, seven members of Expedition 73, including three Americans, are living aboard the ISS – conducting scientific research and working to maintain the station. Social media was flooded with comments in reaction to the sonic boom, and many reported seeing the Dragon as it streaked across the sky as far north as the San Francisco Bay Area and Central Valley. Dragon will also announce its arrival with a brief sonic boom prior to splashing down in the Pacific Ocean — SpaceX (@SpaceX) May 25, 2025 Here is some great video caught it coming thru OC. — Drone Daddy News, OC (@BPW_SERVICES714) May 25, 2025 SpaceX Dragon's departure from ISS The crew members aboard the station spent time Wednesday, May 21, loading and securing a variety of cargo inside the Dragon spacecraft ahead of its scheduled departure. The Dragon has spent 30 days docked to the Harmony module, a port and passageway onto the station facing away from Earth, after arriving April 22 with nearly 6,700 pounds of supplies. The spacecraft launched April 21 on a SpaceX Falcon 9 rocket from NASA's Kennedy Space Center near Cape Canaveral, Florida, for SpaceX's 32nd commercial resupply services mission. Standing nearly 27 feet tall and about 13 feet wide, the Dragon is one of four cargo spacecraft that deliver science experiments and other cargo to the space station on a regular basis. Dragon capsules can also carry up to seven astronauts into orbit, though most of SpaceX's Crew missions, which are contracted with NASA, feature a contingent of four. The Dragon's departure was under command by SpaceX's Mission Control in Hawthorne, California. Eric Lagatta is the Space Connect reporter for the USA TODAY Network. Reach him at elagatta@
Yahoo
an hour ago
- Yahoo
Piezo Stacks with Space-Tested Technology Now Available with Extended Displacement
Quick availability, compact design, excellent temperature stability, humidity resistance, new from PI AUBURN, Mass., June 10, 2025 /PRNewswire-PRWeb/ -- PI, a global leader in precision motion control and nanopositioning, is extending the capabilities of its renowned PICMA® piezo stack actuator series with the introduction of the new PICMA® Plus actuators. While the standard PICMA® actuators are already celebrated for their long lifetime, high stiffness, microsecond response times, and sub-nanometer resolution, the PICMA® Plus line represents a significant advancement by offering substantially greater displacement. Extended Displacement Without Sacrifice Previously, PI's quickly available PICMA® piezo actuators provided displacement ranges from 6.5 microns to 36 microns per monolithic stack. The new PICMA® Plus actuators build upon this proven foundation by delivering even longer travel ranges up to 43 microns, allowing for applications requiring larger displacement in the same package size, without sacrificing the core benefits of the PICMA® technology. Space-Proven Technology - Extreme Lifetime and Operating Temperature Range Both the original and the new PICMA® Plus actuators share the same patented, ceramic-encapsulation process. This proprietary, polymer-free, all-ceramic insulation is what sets PI's actuators apart from conventional, polymer-insulated piezo actuators, which are susceptible to humidity and temperature fluctuations. This robust ceramic encapsulation ensures superior durability and reliability, as demonstrated by NASA/JPL's 100 billion cycle test for the Mars rover Curiosity. The PICMA® technology, including the new Plus variants, continues to offer humidity resistance and a wide operating temperature range from -40°C to 150°C, and up to 200°C for modified versions, making them ideal for challenging environments. Industries Served Micro-manufacturing, nano-dispensing, optics & photonics, semiconductor test equipment, astronomy, biotechnology, surface metrology, quality assurance, nanometrology, nanopositioning Specifications, datasheet: Achieving High Precision with Multilayer Piezo Linear Actuators Read the blog posts: Small Motion Steps Yield Big Effects in the Quest for Life on Mars Reliable Piezo Motion Devices for Industrial and Space Applications PI Americas | info@ | (508) 832-3456 Applications Blog | Videos | LinkedIn Media Contact PI Press Releases, PI (Physik Instrumente) LP, (508) 832-3456, press-release@ View original content to download multimedia: SOURCE PI (Physik Instrumente) LP Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
ST. PAUL, Minn., June 10, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Immuneel Therapeutics has been awarded a $150,000 G-Rex® Grant to support process development aimed at enhancing the scalability and cost-effectiveness of CAR-T cell manufacturing in India. "The blood cancer burden on India's population is substantial, around 120,000 new cases of lymphoma, leukemia, and multiple myeloma are diagnosed each year. Unfortunately, almost 70,000 Indians will die every year from these afflictions, devastating the lives of their families and communities. To afford access to all Indian patients in need, and to capitalize on the immense commercial potential of our pipeline, we need to think prudently and practically about our manufacturing approach. In the short term, our manufacturing demands are almost 200 drug products per day, and this may increase as CAR-T cell therapies move closer to front line treatment. The only practical way for us to industrialize our production and produce a supply of drug product commensurate with total patient demand is to transition to G-Rex," said Dr. Lakshmikanth Gandikota, Head of R&D, MSAT Intellectual Property, and Translational Research, at Immuneel Therapeutics Limited. "We are extremely impressed by the speed, resourcefulness, creativity, discipline, and entrepreneurialism of the team at Immuneel and are happy to see that India, as a whole, is making significant strides toward CAR-T availability. It gives us a great sense of satisfaction to be in a position to help bring hope to cancer patients in India, one G-Rex at a time," said John Wilson, CEO of Wilson Wolf and co-inventor of G-Rex. As part of Immuneel's G-Rex Grant, they will perform process development, qualification, and validation of a G-Rex based CAR-T cell therapy production approach to dramatically increase the throughput capacity of their state-of-the-art, 12,000 square foot GMP facility. Located in Bengaluru and opened in 2021, Immuneel's Integrated Cell Therapy Development and Manufacturing Facility was the first of its kind in India and is designed to bring breakthrough cell and gene therapies to millions of patients in India. Lastly, Immuneel's G-Rex Grant will support the requisite comparability studies necessary to support a post-CAR-T approval manufacturing change from their difficult to scale low throughput all-in-one manufacturing equipment to a much simpler high throughput G-Rex centric approach. The high popularity of ScaleReady's G-Rex Grant Program led ScaleReady to increase award funds from the original amount of $20M to a total of $30M directed towards saving recipients significant time and money by expediting the path to optimized cell and gene-modified cell therapy manufacturing. Two hundred grants have already been awarded with over 50 new applications in the queue. Each G-Rex Grant recipient can obtain up to $300,000 and gain access to exclusive support from ScaleReady's growing consortium of G-Rex Grant Partners who bring best-in-class tools and technologies as well as unparalleled knowledge and expertise in the areas of cGMP manufacturing, quality and regulatory affairs, CGT business operations, and more. For more information about the G-Rex® Grant Program, please contact info@ About ScaleReadyScaleReady provides the field of cell and gene-modified cell therapy (CGT) with a G-Rex centric manufacturing platform that enables the world's most practical, flexible, scalable, and affordable CGT drug product development and manufacturing. The G-Rex manufacturing platform is currently used by a rapidly growing list of over 800 organizations and is producing drug products for approximately 50% of CGT clinical trials as well as 5 commercially approved CGT drugs. CGT entities relying on the breadth and scope of ScaleReady's expertise can expect to save years of time and millions of dollars on the path to CGT commercialization. For more information about the ScaleReady G-Rex® Grant Program, please contact info@ About Wilson Wolf ManufacturingWilson Wolf ( is dedicated to simplifying cell and gene-modified cell (CGT) therapy research, process development, and manufacturing. This is being accomplished through its scalable G-Rex technology, which is used throughout the world in CGT applications ranging from basic research to commercial drug production. Wilson Wolf's mission is to create hope for cancer patients, one G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex® Bioreactors, including right-sized reagent quantities in containers that are tailored to high throughput closed-system manufacturing. For more information on Bio-Techne and its brands, please visit or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube. Contact: David Clair, Vice President, Investor Relations & Corporate About CellReady LLCCellReady is the world's first and only G-Rex centric contract development and manufacturing organization (CDMO) specializing in G-Rex based cell and gene-modified cell therapy development and manufacturing. The company offers a wide range of services to support the development and commercialization of these therapies. CellReady's mission is to create hope for cancer patients, one G-Rex® process at a time. About Immuneel therapeutics Private LimitedImmuneel Therapeutics Private Limited is a cutting-edge biotechnology company based in Bangalore, India, at the forefront of advancing cell and gene therapies, as well as personalized immunotherapies, for cancer patients in India. As a research-driven and fully integrated organization, Immuneel is dedicated to making next-generation cancer treatments accessible and affordable, with a strong focus on innovation and clinical impact. The company's mission is to democratize advanced therapies by developing and commercializing breakthrough solutions tailored to the needs of Indian patients. As part of its growing portfolio, Immuneel has licensed and commercialized Qartemi® (varnimcabtagene autoleucel), a CD19 CAR-T cell therapy approved by India's Central Drugs Standard Control Organization (CDSCO) for the treatment of adult B-cell non-Hodgkin lymphoma a novel therapy for blood cancer, further demonstrating its commitment to transforming cancer care in India. Immuneel has a robust pipeline of CAR-T therapies for various indications in Oncology and AutoImmune diseases For more information, please visit: View original content to download multimedia: SOURCE Bio-Techne Corporation